DIGBI HEALTH

Operating

Food RX and IA, Inc (DBA Digbi Health)

Healthcare · Founded 2019

Visit website

Groundbreaking care for obesity and digestive health

Post-money valuation ⓘ

$60.8M

As of Nov 2024 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price

Total raised

$1,371,588

Crowd $0 · Private $1.4M · 2 rounds since 2022

Latest share price

$0.6865

Rule 506(b) · Preferred Series A Shares · Apr 2022 offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source

$566K

−$3.0M

2022

$620K

−$2.6M

2023

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2022 reviewed

FY2023 reviewed

Income statement

Revenue

$565,836

$620,458

Cost of goods sold

$148,811

$133,415

Gross margin

74%

78%

Net income

-$3,000,547

-$2,646,937

Taxes paid

Balance sheet

Cash

$273,249

$243,256

Accounts receivable

$42,968

Total assets

$487,894

$445,748

Short-term debt

$588,725

$691,700

Long-term debt

$818,000

$3,166,451

Total liabilities

$1,406,725

$3,858,151

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in

$60.8M

pre-money

Reg CF · Preferred · Sep 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Preferred Stock · Sep 2024Closedvia StartEngine

Raised $0 / $1.2MInvestors 10Post-money $60.8M

Rule 506(b) · Preferred Series A Shares · Apr 2022Closed

Raised $1.4M

Team

4 people

Priyaranjan Sinha

CEO and Director, principal financial officer

Ashok Belani

Director

Mark Ganz

Director

Salomon Sredni

Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 2 annual reports (FY2024–FY2025)

Missing: 2024, 2025

10 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

Form C-UNov 15, 20240001665160-24-001624
EDGAR
Form CSep 23, 20240001665160-24-001334
EDGAR

Source: ManualCIK 0002034167Share price $2.00

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.